Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$533M |
| 2 |
Apple
AAPL
|
+$347M |
| 3 |
Micron Technology
MU
|
+$272M |
| 4 |
Eli Lilly
LLY
|
+$232M |
| 5 |
Super Micro Computer
SMCI
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$472M |
| 2 |
NVIDIA
NVDA
|
+$413M |
| 3 |
Tesla
TSLA
|
+$403M |
| 4 |
Coinbase
COIN
|
+$236M |
| 5 |
Johnson & Johnson
JNJ
|
+$224M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.66% |
| 2 | Healthcare | 16.81% |
| 3 | Consumer Discretionary | 13.04% |
| 4 | Industrials | 9.63% |
| 5 | Financials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Energy Services of America
ESOA
$293M
| $1.63M | ﹤0.01% |
171,700
-32,192
| -16% | -$275K |
|
2152
Voyager Therapeutics
VYGR
$189M
| $1.63M | ﹤0.01% |
278,667
+215,467
| +341% | +$1.57M |
|
2153
Talos Energy
TALO
$2.35B
| $1.63M | ﹤0.01% |
+157,185
| New | +$1.79M |
|
2154
Suzano
SUZ
$10.2B
| $1.62M | ﹤0.01% |
162,486
+136,270
| +520% | +$1.33M |
|
2155
Hagerty
HGTY
$1.37B
| $1.62M | ﹤0.01% |
159,396
+75,200
| +89% | +$833K |
|
|
JAMF
2156
DELISTED
Jamf
JAMF
| $1.62M | ﹤0.01% |
93,400
-88,800
| -49% | -$1.58M |
|
|
OGI
2157
Organigram Holdings
OGI
$139M
| $1.62M | ﹤0.01% |
893,448
+76,500
| +9% | +$133K |
|
2158
Crown Crafts
CRWS
$32.3M
| $1.61M | ﹤0.01% |
336,342
+19,400
| +6% | +$93.7K |
|
2159
FlexShares High Yield Value-Scored Bond Index Fund
HYGV
$1.1B
| $1.61M | ﹤0.01% |
38,700
-33,400
| -46% | -$1.37M |
|
2160
Cardiff Oncology
CRDF
$74.7M
| $1.61M | ﹤0.01% |
602,384
+444,894
| +282% | +$1.05M |
|
2161
3D Systems Corp
DDD
$588M
| $1.61M | ﹤0.01% |
+565,950
| New | +$1.63M |
|
2162
NMI Holdings
NMIH
$3.31B
| $1.6M | ﹤0.01% |
38,853
+28,053
| +260% | +$1.08M |
|
2163
Carter Bankshares
CARE
$751M
| $1.59M | ﹤0.01% |
91,400
+8,300
| +10% | +$136K |
|
2164
Kodiak Sciences
KOD
$2.84B
| $1.59M | ﹤0.01% |
607,750
-101,050
| -14% | -$269K |
|
|
DOO
2165
Bombardier Recreational Products
DOO
$4.68B
| $1.58M | ﹤0.01% |
26,600
-11,600
| -30% | -$769K |
|
2166
Viasat
VSAT
$11.3B
| $1.58M | ﹤0.01% |
+132,522
| New | +$2.14M |
|
2167
Aclaris Therapeutics
ACRS
$851M
| $1.58M | ﹤0.01% |
1,370,700
+448,500
| +49% | +$550K |
|
|
ADAP
2168
DELISTED
Adaptimmune Therapeutics
ADAP
| $1.57M | ﹤0.01% |
1,656,575
-129,766
| -7% | -$147K |
|
2169
Montauk Renewables
MNTK
$242M
| $1.57M | ﹤0.01% |
302,100
+67,800
| +29% | +$339K |
|
2170
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.7B
| $1.57M | ﹤0.01% |
26,500
+5,300
| +25% | +$304K |
|
|
EHAB
2171
DELISTED
Enhabit
EHAB
| $1.57M | ﹤0.01% |
198,168
+129,268
| +188% | +$1.12M |
|
2172
Everspin Technologies
MRAM
$367M
| $1.56M | ﹤0.01% |
264,767
-15,839
| -6% | -$92K |
|
|
RPTX
2173
DELISTED
Repare Therapeutics
RPTX
| $1.56M | ﹤0.01% |
453,700
-5,000
| -1% | -$16.5K |
|
2174
Valens Semiconductor
VLN
$182M
| $1.56M | ﹤0.01% |
708,700
+74,400
| +12% | +$176K |
|
2175
GoPro
GPRO
$126M
| $1.56M | ﹤0.01% |
1,145,800
+92,000
| +9% | +$127K |
|
Similar funds
Renaissance Technologies's Q3 2024 Portfolio in Review
As of Q3 2024, Renaissance Technologies held 4,024 positions worth $66.5B, up 13% from $59B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies deployed $3.2B of net new capital in Q3 2024, opening 578 new positions and adding to 1,558 existing holdings. Its largest new stake was Micron Technology: 2,604,914 shares worth $270M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $413M trimmed.
- Renaissance Technologies's largest Q3 2024 buy was Micron Technology: 2,604,914 shares worth $270M.
- Renaissance Technologies added most to Microsoft in Q3 2024, an estimated $533M increase.
- Renaissance Technologies's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $413M.
- Renaissance Technologies fully exited Broadcom in Q3 2024, selling an estimated $472M.
- Renaissance Technologies's ten largest holdings make up 11% of its $66.5B portfolio in Q3 2024.
- Renaissance Technologies opened 578 new positions and closed 539 in Q3 2024.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $66.5B.
Based on Renaissance Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.